In the News

BioCare Named To 2023 Financial Times List Of The Americas’ Fastest Growing Companies

Post Date: March 30, 2023

BioCare, Inc., a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy, and logistics services, has been recognized by the Financial Times as one of “The Americas’ Fastest Growing Companies 2023.” The list, compiled by the Financial Times...

BioCareSD and AllyRetina GPO Partner to Help Retina Providers Improve Patient Care and Increase Efficiency

Post Date: March 17, 2023

BioCareSD announced its partnership with AllyRetina. Debuting at the American Society of Retina Specialists (ASRS) 24th Annual Business of Retina conference this week, AllyRetina will serve its GPO members through its physician leadership, a seasoned management team,...

BioCare CIO Cory Shouse Named Finalist for 2023 Dallas CIO of the Year ORBIE Awards

Post Date: March 8, 2023

BioCare, a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy, and logistics services, today announced that its Chief Information Officer (CIO), Cory Shouse, was selected by the ORBIE Awards committee as a finalist for...

Andrew Kirk, Chief Revenue Officer of BioCare, on “How to Plan for a Rail Strike”

Post Date: February 24, 2023

The country is breathing a collective sigh of relief as a rail strike was narrowly avoided this past year. While we were able to steer clear of it this time, it got many people thinking about...

BioCare Names Two Healthcare Industry Veterans to Leadership Positions

Post Date: February 7, 2023

BioCare, Inc., specializing in delivering specialty and therapeutic biological products since 1982, has named two healthcare industry veterans to their leadership team. Healthcare sales executive Mike Collins was named Vice President of Sales for BioCareSD, the company's specialty...

BioCareSD Strengthens Its Specialty Therapeutics Portfolio with the Addition of LEQEMBI™

Post Date: January 20, 2023

BioCareSD, a specialty distributor of life-saving therapies, is proud to announce the addition of LEQEMBI to their diverse portfolio of specialty therapeutics. LEQEMBI was recently approved by the U.S. Food and Drug Administration (FDA) under the...

Andrew Kirk, Chief Revenue Officer of BioCare, on “Creating A Sense Of Togetherness For Your Team In A Remote Work Environment”

Post Date: December 19, 2022

For the past two and a half years, organizations have had to learn to operate across remote and hybrid environments at an unprecedented rate. Initially, the issues that stemmed from immediate and widespread remote work were plentiful:...

BioCareSD Adds VIBATIV® and ULTOMIRIS® to Specialty Therapeutics Portfolio

Post Date: December 9, 2022

BioCareSD, a specialty distributor of life-saving therapies, today announced the addition of VIBATIV® and ULTOMIRIS® to its already extensive portfolio of life-saving therapies. With an ongoing commitment to broadening its product portfolio, BioCareSD is dedicated to...

Andrew Kirk of BioCare details “the Potential Rail Strike Impact on the Supply Chain, as Negotiations Hit an Impasse”

Post Date: November 16, 2022

Supply chain professionals must consider immediate impacts and contemplate possible implications for materials. As always, in developing internal supply chains, evaluating vendors and supplies, contingency planning, and communication will be critical. This major challenge highlights the need for...

Tom Hart, Chief Operating Officer of BioCare, on “How Extreme Weather Affects Cold Supply Chains”

Post Date: November 11, 2022

Cold supply chains are necessary to ensure the efficacy of certain medications, vaccines and other biopharmaceutical products, but the addition of extreme temperatures presents new obstacles that can make the process even more difficult to manage...